© The European Society of Cardiology, the American College of Cardiology Foundation, the American Heart Association, and the World Heart Federation 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Universal definition of myocardial infarction
Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction
Task Force Members,
(Denmark)
(USA)
(New Zealand)
(USA)
(USA)
(Italy)
(Germany)
(USA)
(Denmark)
(USA)
(Denmark)
(Sweden)
(Israel)
(Finland)
(UK)
(The Netherlands)
(USA)
(USA)
(The Netherlands)
(France)
(Belgium)
(USA)
(France)
(USA)
(USA)
(Canada)
(USA)
(UK)
(Germany)
(USA)
(The Netherlands)
(UK)
(Argentina)
(Spain)
(India)
(Switzerland)
(China)
(Sweden)
(Spain)
(UK)
(Ukraine)
(Italy)
(Poland)
(Finland)
ESC Committee for Practice Guidelines,
(France)
(UK)
(Italy)
(France)
(Norway)
(Greece)
(France)
(The Netherlands)
(Denmark)
(France)
(Germany)
(Germany)
(Poland)
(Czech Republic)
(Spain)
Document Reviewers,
(Portugal)
(USA)
(USA)
(USA)
(Germany)
(Singapore)
(Mexico)
(USA)
(USA)
(USA)
(USA)
(Italy)
(Poland)
(France)
* Corresponding authors/co-chairpersons. Professor Kristian Thygesen, Department of Medicine and Cardiology, Aarhus University Hospital, Tage Hansens, Gade 2, DK-8000 Aarhus C, Denmark. Tel: +45 89 49 76 14; fax: +45 89 49 76 19. E-mail: Kristian.Thygesen@as.aaa.dk. Professor Joseph Alpert, Department of Medicine, University of Arizona College of Medicine, 1501 N. Campbell Ave, PO Box 245017, Tucson, AZ 85724-5017, USA. Tel: +1 520 626 6138; fax: +1 520 626 6604. E-mail: jalpert@email.arizona.edu. Professor Harvey White, Green Lane Cardiovascular Service, Auckland City Hospital, Private Bag 92024, 1030 Auckland, New Zealand. Tel: +64 96309992; fax: +64 96309915. E-mail: harveyw@adhb.govt.nz
The recommendations set forth in this report are those of the Task Force Members and do not necessarily reflect the official position of the American College of Cardiology.
Dr Shanti Mendis of the WHO participated in the task force in her personal capacity, but this does not represent WHO approval of this document at the present time. ![]()
This article has been copublished in the October II (Vol. 28 no. 20), 2007, issue of the European Heart Journal (also available on the Web site of the European Society of Cardiology at www.escardio.org), the November 27, 2007, issue of Circulation (also available on the Web site of the American Heart Association at my.americanheart.org), and the November 27, 2007, issue of the Journal of the American College of Cardiology (also available on the Web site of the American College of Cardiology at www.acc.org).
This document was approved by the European Society
| Introduction |
|---|
Clinical features of ischaemia
Pathology
Clinical classification of myocardial infarction
| Biomarker evaluation |
|---|
Reinfarction
| Electrocardiographic detection of myocardial infarction |
|---|
ECG abnormalities of myocardial ischaemia that may evolve to myocardial infarction
Prior myocardial infarction
Conditions that confound the ECG diagnosis of myocardial infarction
Reinfarction
Coronary revascularization
| Imaging techniques |
|---|
Echocardiography
Radionuclide imaging
Magnetic resonance imaging
X-Ray computed tomography
Application in the acute phase of myocardial infarction
Application in the healing or healed phase of myocardial infarction
| Myocardial infarction associated with revascularization procedures |
|---|
Diagnostic criteria for myocardial infarction with PCI
Diagnostic criteria for myocardial infarction with CABG
| Definition of myocardial infarction in clinical investigations |
|---|
| Public policy implications of redefinition of myocardial infarction |
|---|
| Global perspectives of the redefinition of myocardial infarction |
|---|
| Conflicts of interest |
|---|
| Acknowledgements |
|---|
| Footnotes |
|---|
| References |
|---|
Related articles in EHJ:
- Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction
- Task Force Members, Kristian Thygesen, Joseph S. Alpert, Harvey D. White, Biomarker Group, Allan S. Jaffe, Fred S. Apple, Marcello Galvani, Hugo A. Katus, L. Kristin Newby, Jan Ravkilde, ECG Group, Bernard Chaitman, Peter M. Clemmensen, Mikael Dellborg, Hanoch Hod, Pekka Porela, Imaging Group, Richard Underwood, Jeroen J. Bax, George A. Beller, Robert Bonow, Ernst E. Van Der Wall, Intervention Group, Jean-Pierre Bassand, William Wijns, T. Bruce Ferguson, Philippe G. Steg, Barry F. Uretsky, David O. Williams, Clinical Investigation Group, Paul W. Armstrong, Elliott M. Antman, Keith A. Fox, Christian W. Hamm, E. Magnus Ohman, Maarten L. Simoons, Global Perspective Group, Philip A. Poole-Wilson, Enrique P. Gurfinkel, José-Luis Lopez-Sendon, Prem Pais, Shanti Mendis, Jun-Ren Zhu, Implementation Group, Lars C. Wallentin, Francisco Fernández-Avilés, Kim M. Fox, Alexander N. Parkhomenko, Silvia G. Priori, Michal Tendera, Liisa-Maria Voipio-Pulkki, ESC Committee for Practice Guidelines, Alec Vahanian, A. John Camm, Raffaele De Caterina, Veronica Dean, Kenneth Dickstein, Gerasimos Filippatos, Christian Funck-Brentano, Irene Hellemans, Steen Dalby Kristensen, Keith McGregor, Udo Sechtem, Sigmund Silber, Michal Tendera, Petr Widimsky, José Luis Zamorano, Document Reviewers, Joao Morais, Sorin Brener, Robert Harrington, David Morrow, Udo Sechtem, Michael Lim, Marco A. Martinez-Rios, Steve Steinhubl, Glen N. Levine, W. Brian Gibler, David Goff, Marco Tubaro, Darek Dudek, and Nawwar Al-Attar
EHJ 2007 28: 2525-2538.[Extract] [FREE Full Text]
This article has been cited by other articles:
![]() |
G. Heusch, P. Kleinbongard, D. Bose, B. Levkau, M. Haude, R. Schulz, and R. Erbel Coronary Microembolization: From Bedside to Bench and Back to Bedside Circulation, November 3, 2009; 120(18): 1822 - 1836. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. White Is there an acceptable ceiling for bleeding for an antithrombotic drug dose to be tested in a phase 3 trial? Eur. Heart J., November 1, 2009; 30(21): 2556 - 2557. [Full Text] [PDF] |
||||
![]() |
N. J. Verouden, K. Barwari, K. T. Koch, J. P. Henriques, J. Baan, R. J. van der Schaaf, M. M. Vis, R. B. van den Brink, J. J. Piek, J. G. Tijssen, et al. Distinguishing the right coronary artery from the left circumflex coronary artery as the infarct-related artery in patients undergoing primary percutaneous coronary intervention for acute inferior myocardial infarction Europace, November 1, 2009; 11(11): 1517 - 1521. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Trevisanuto, N Doglioni, S Altinier, M Zaninotto, M Plebani, and V Zanardo Cardiac troponin I at birth is of fetal-neonatal origin Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2009; 94(6): F464 - F466. [Abstract] [Full Text] [PDF] |
||||
![]() |
N J Verouden, K T Koch, R J Peters, J P Henriques, J Baan, R J van der Schaaf, M M Vis, J G Tijssen, J J Piek, H J Wellens, et al. Persistent precordial "hyperacute" T-waves signify proximal left anterior descending artery occlusion Heart, October 15, 2009; 95(20): 1701 - 1706. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S.P. Sharp, A. Latib, A. Ielasi, C. Larosa, C. Godino, M. Saolini, V. Magni, R. T. Gerber, M. Montorfano, M. Carlino, et al. Long-Term Follow-Up on a Large Cohort of "Full-Metal Jacket" Percutaneous Coronary Intervention Procedures Circ Cardiovasc Interv, October 1, 2009; 2(5): 416 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Widera, R. Horn-Wichmann, T. Kempf, K. Bethmann, B. Fiedler, S. Sharma, R. Lichtinghagen, H. Leitolf, B. Ivandic, H. A. Katus, et al. Circulating Concentrations of Follistatin-Like 1 in Healthy Individuals and Patients with Acute Coronary Syndrome as Assessed by an Immunoluminometric Sandwich Assay Clin. Chem., October 1, 2009; 55(10): 1794 - 1800. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Morrow Clinical Application of Sensitive Troponin Assays N. Engl. J. Med., August 27, 2009; 361(9): 913 - 915. [Full Text] [PDF] |
||||
![]() |
C. Briguori, G. Visconti, A. Focaccio, B. Golia, A. Chieffo, A. Castelli, M. Mussardo, M. Montorfano, B. Ricciardelli, and A. Colombo Novel Approaches for Preventing or Limiting Events (Naples) II Trial: Impact of a Single High Loading Dose of Atorvastatin on Periprocedural Myocardial Infarction J. Am. Coll. Cardiol., August 5, 2009; (2009) j.jacc.2009.07.005v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J.E. Sattler, J. Herrmann, S. Yun, N. Lehmann, Z. Wang, G. Heusch, S. Sack, R. Erbel, and B. Levkau High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention Eur. Heart J., August 1, 2009; 30(15): 1894 - 1902. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Muehlschlegel, T. E. Perry, K.-Y. Liu, L. Nascimben, A. A. Fox, C. D. Collard, E. G. Avery, S. F. Aranki, M. N. D'Ambra, S. K. Shernan, et al. Troponin is superior to electrocardiogram and creatinine kinase MB for predicting clinically significant myocardial injury after coronary artery bypass grafting Eur. Heart J., July 1, 2009; 30(13): 1574 - 1583. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H Jacobs, J. van de Kerkhof, A. M Mingels, V. W Kleijnen, F. M van der Sande, W. K Wodzig, J. P Kooman, and M. P van Dieijen-Visser Haemodialysis patients longitudinally assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and cardiac troponin I assays Ann Clin Biochem, July 1, 2009; 46(4): 283 - 290. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. Apple A New Season for Cardiac Troponin Assays: It's Time to Keep a Scorecard Clin. Chem., July 1, 2009; 55(7): 1303 - 1306. [Full Text] [PDF] |
||||
![]() |
APPRAISE Steering Committee and Investigators Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome: Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial Circulation, June 9, 2009; 119(22): 2877 - 2885. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Morrow, S. D. Wiviott, H. D. White, J. C. Nicolau, E. Bramucci, S. A. Murphy, M. P. Bonaca, C. T. Ruff, B. M. Scirica, C. H. McCabe, et al. Effect of the Novel Thienopyridine Prasugrel Compared With Clopidogrel on Spontaneous and Procedural Myocardial Infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38: An Application of the Classification System From the Universal Definition of Myocardial Infarction Circulation, June 2, 2009; 119(21): 2758 - 2764. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Testa, W.J. Van Gaal, G.G.L. Biondi Zoccai, P. Agostoni, R.A. Latini, F. Bedogni, I. Porto, and A.P. Banning Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition QJM, June 1, 2009; 102(6): 369 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Di Chiara and D. Vanuzzo Does surveillance impact on cardiovascular prevention? Eur. Heart J., May 1, 2009; 30(9): 1027 - 1029. [Full Text] [PDF] |
||||
![]() |
R K Riezebos, E Ronner, E ter Bals, T Slagboom, P C Smits, J M ten Berg, F Kiemeneij, G Amoroso, M S Patterson, M J Suttorp, et al. Immediate versus deferred coronary angioplasty in non-ST-segment elevation acute coronary syndromes Heart, May 1, 2009; 95(10): 807 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kaul and G. A. Diamond Intravascular Ultrasound Tissue Characterization: Messages From the Heart J. Am. Coll. Cardiol. Img., April 1, 2009; 2(4): 469 - 472. [Full Text] [PDF] |
||||
![]() |
R. R.J. van Kimmenade and J. L. Januzzi Jr Whose heart will get broken? Troponin testing and future heart failure Eur. Heart J., April 1, 2009; 30(7): 755 - 756. [Full Text] [PDF] |
||||
![]() |
J. Sanchis, V. Bodi, J. Nunez, L. Mainar, E. Nunez, P. Merlos, E. Rumiz, G. Minana, X. Bosch, and A. Llacer Efficacy of Coronary Revascularization in Patients With Acute Chest Pain Managed in a Chest Pain Unit Mayo Clin. Proc., April 1, 2009; 84(4): 323 - 329. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Stellos, B. Bigalke, H. Langer, T. Geisler, A. Schad, A. Kogel, F. Pfaff, D. Stakos, P. Seizer, I. Muller, et al. Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells Eur. Heart J., March 1, 2009; 30(5): 584 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Svircevic, A. P. Nierich, K. G. M. Moons, G. J. Brandon Bravo Bruinsma, C. J. Kalkman, and D. van Dijk Fast-Track Anesthesia and Cardiac Surgery: A Retrospective Cohort Study of 7989 Patients Anesth. Analg., March 1, 2009; 108(3): 727 - 733. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Jaffe and F. S. Apple Refining Our Criteria: A Critical Challenge Am J Clin Pathol, January 1, 2009; 131(1): 11 - 13. [Full Text] [PDF] |
||||
![]() |
A. M. Jansson, H. Rosjo, T. Omland, T. Karlsson, M. Hartford, A. Flyvbjerg, and K. Caidahl Prognostic value of circulating chromogranin A levels in acute coronary syndromes Eur. Heart J., January 1, 2009; 30(1): 25 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Morrow and E. M. Antman Evaluation of High-Sensitivity Assays for Cardiac Troponin Clin. Chem., January 1, 2009; 55(1): 5 - 8. [Full Text] [PDF] |
||||
![]() |
F. S. Apple, S. W. Smith, L. A. Pearce, and M. M. Murakami Assessment of the Multiple-Biomarker Approach for Diagnosis of Myocardial Infarction in Patients Presenting with Symptoms Suggestive of Acute Coronary Syndrome Clin. Chem., January 1, 2009; 55(1): 93 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mingels, L. Jacobs, E. Michielsen, J. Swaanenburg, W. Wodzig, and M. van Dieijen-Visser Reference Population and Marathon Runner Sera Assessed by Highly Sensitive Cardiac Troponin T and Commercial Cardiac Troponin T and I Assays Clin. Chem., January 1, 2009; 55(1): 101 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Cosío, J.#x. Palacios, A.#x.;n Pastor, and A. Núñez CHAPTER 2 The Electrocardiogram ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Hamm, H. Möllmann, J.-P. Bassand, and F. van de Werf CHAPTER 16 Acute Coronary Syndromes ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Atar New definition of myocardial infarction BMJ, December 24, 2008; 337(dec24_1): a3078 - a3078. [Full Text] |
||||
![]() |
C. J. McCann, B. M. Glover, I. B.A. Menown, M. J. Moore, J. McEneny, C. G. Owens, B. Smith, P. C. Sharpe, I. S. Young, and J. A. Adgey Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T Eur. Heart J., December 1, 2008; 29(23): 2843 - 2850. [Abstract] [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members, F. Van de Werf, J. Bax, A. Betriu, C. Blomstrom-Lundqvist, F. Crea, V. Falk, G. Filippatos, K. Fox, K. Huber, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology: Eur. Heart J., December 1, 2008; 29(23): 2909 - 2945. [Full Text] [PDF] |
||||
![]() |
J. Ravkilde Markers in Cardiology: A Case-Orientated Approach. Jesse E. Adams, Fred S. Apple, and Allan S. Jaffe, editors. Malden, MA: Blackwell Futura Publishing, 2007, 261 pp, $99.95. ISBN 978-1-4051-3418-7. Clin. Chem., December 1, 2008; 54(12): 2090 - 2091. [Full Text] [PDF] |
||||
![]() |
D. N. Tziakas, G. K. Chalikias, I. K. Tentes, D. Stakos, S. V. Chatzikyriakou, K. Mitrousi, A. X. Kortsaris, J. C. Kaski, and H. Boudoulas Interleukin-8 is increased in the membrane of circulating erythrocytes in patients with acute coronary syndrome Eur. Heart J., November 2, 2008; 29(22): 2713 - 2722. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Goran Suggestion to list acute aortic dissection as a possible cause of type 2 myocardial infarction (according to the universal definition) Eur. Heart J., November 2, 2008; 29(22): 2819 - 2820. [Full Text] [PDF] |
||||
![]() |
J. L. Saver Proposal for a Universal Definition of Cerebral Infarction Stroke, November 1, 2008; 39(11): 3110 - 3115. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Empana, F. Canoui-Poitrine, G. Luc, I. Juhan-Vague, P. Morange, D. Arveiler, J. Ferrieres, P. Amouyel, A. Bingham, M. Montaye, et al. Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study Eur. Heart J., August 2, 2008; 29(16): 1966 - 1974. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Antman and D. A. Morrow Biomarker Release After Percutaneous Coronary Intervention: A Message From the Heart Circ Cardiovasc Interv, August 1, 2008; 1(1): 3 - 6. [Full Text] [PDF] |
||||
![]() |
P. W Armstrong Defining myocardial infarction: a work in progress Heart, August 1, 2008; 94(8): 1076 - 1079. [Full Text] [PDF] |
||||
![]() |
N. Johnston, H. Dargie, and A. Jardine Diagnosis and treatment of coronary artery disease in patients with chronic kidney disease Heart, August 1, 2008; 94(8): 1080 - 1088. [Full Text] [PDF] |
||||
![]() |
T. Ilva, J. Lassus, K. Siirila-Waris, J. Melin, K. Peuhkurinen, K. Pulkki, M. S. Nieminen, H. Mustonen, P. Porela, and V.-P. Harjola Clinical significance of cardiac troponins I and T in acute heart failure Eur J Heart Fail, August 1, 2008; 10(8): 772 - 779. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gray, S. Goodacre, D. E. Newby, M. Masson, F. Sampson, J. Nicholl, and the 3CPO Trialists Noninvasive Ventilation in Acute Cardiogenic Pulmonary Edema N. Engl. J. Med., July 10, 2008; 359(2): 142 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Schiele, N. Meneveau, and J.-P. Bassand Routine pre-treatment with clopidogrel before diagnostic coronary angiography: the question is right, but what about the answer? Eur. Heart J., June 2, 2008; 29(12): 1475 - 1477. [Full Text] [PDF] |
||||
![]() |
G. A. Lanza The universal definition of myocardial infarction: some issues and concerns Eur. Heart J., May 1, 2008; 29(9): 1209 - 1209. [Full Text] [PDF] |
||||
![]() |
K. Thygesen, J. S. Alpert, A. S. Jaffe, H. D. White, and On behalf of the Joint ESC/ACCF/AHA/WHF Task Force The universal definition of myocardial infarction: some issues and concerns: reply Eur. Heart J., May 1, 2008; 29(9): 1209 - 1210. [Full Text] [PDF] |
||||
![]() |
MEND-CABG II Investigators* Efficacy and Safety of Pyridoxal 5'-Phosphate (MC-1) in High-Risk Patients Undergoing Coronary Artery Bypass Graft Surgery: The MEND-CABG II Randomized Clinical Trial JAMA, April 16, 2008; 299(15): 1777 - 1787. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. Apple, S. W. Smith, L. A. Pearce, R. Ler, and M. M. Murakami Use of the Centaur TnI-Ultra Assay for Detection of Myocardial Infarction and Adverse Events in Patients Presenting With Symptoms Suggestive of Acute Coronary Syndrome Clin. Chem., April 1, 2008; 54(4): 723 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. H.J. Pijls, P. van Schaardenburg, G. Manoharan, E. Boersma, J.-W. Bech, M. van't Veer, F. Bar, J. Hoorntje, J. Koolen, W. Wijns, et al. Reply. J. Am. Coll. Cardiol., March 18, 2008; 51(11): 1123 - 1124. [Full Text] [PDF] |
||||
![]() |
E. Siniorakis, G. Kirvassilis, and N. Exadactylos Intraoperative myocardial infarction in non-cardiac surgery: is a universal definition feasible? Eur. Heart J., February 2, 2008; 29(4): 567 - 567. [Full Text] [PDF] |
||||
![]() |
K. Thygesen, J. S. Alpert, A. S. Jaffe, H. D. White, and On behalf of the Joint ESC/ACCF/AHA/WHF Task Force Intraoperative myocardial infarction in non-cardiac surgery: is a universal definition feasible? reply Eur. Heart J., February 2, 2008; 29(4): 567 - 568. [Full Text] [PDF] |
||||
![]() |
P. Collinson, K. Pulkki, J. Suvisaari, J. Ravkilde, A. Stavljenic-Rukavina, A. Hammerer-Lercher, H. Baum, M. P. van Dieijen-Visser, and P. H. Laitinen How Well Do Laboratories Follow Guidelines on Cardiac Markers? The Cardiac Marker Guideline Uptake in Europe Study Clin. Chem., February 1, 2008; 54(2): 448 - 449. [Full Text] [PDF] |
||||



















